
Swiss stock market sets yet another record high
Keystone-SDA
The Swiss stock market has got off to a flying start this week and has already set new record highs. Once again, the domestic stock market has been buoyed by its defensive blue-chip stocks.
According to stock market traders, there is currently a great deal of uncertainty in the technology sector – both with regard to the planned IPO of the AI platform operator Anthropic and the future performance of the semiconductor group Nvidia. Thanks to its defensive nature, the Swiss stock market is less affected by this than other stock exchanges.
More

More
Swiss retail investors risk Anthropic IPO disappointment
By the close of trading on Monday, the SMI had risen by 0.6% to 15,192 points. It hit an all-time high of 15,272 in the afternoon. Afterwards, following a weak start to trading on Wall Street, share prices slipped back slightly. Meanwhile, other major European indices, such as the German DAX and the French CAC 40, closed lower.
At the top of the SMI, Richemont (+2.7%) began to recover. On Friday, annual results that had not been well received had driven the shares down by 3.8%.
Behind Richemont, healthcare shares were particularly in demand, setting the tone for the market. Alcon and Novartis rose by 1.3%, Roche by 1.1% and Lonza by 0.6%.
Shares from the broader chip and AI sectors were in low demand. Experts spoke of a noticeable “tech hangover”, which, however, had only had a limited impact in Switzerland.
Consequently, ABB (-1.1%), VAT (-0.6%) and, in the broader market, Comet (-1.6%), Huber+Suhner (-1.6%) and Inficon (-1.5%) all saw relatively moderate losses. However, traders noted that a certain degree of nervousness was palpable ahead of tomorrow’s Nvidia results.
More

More
Republican blame game, alleged Nvidia honeytrap, and a NASA job offer
+ How we produce news in English
Translated from German, reviewed by an English Department journalist.


